Zhengzhou Zhongpu Medical Device Co., LTD
Zhengzhou Zhongpu Medical Equipment Co., Ltd.
Zhengzhou ZOPOMED Medical Equipment Co., Ltd., founded in 2010 and located in the High-tech Zone of Zhengzhou City, is a high-tech enterprise focusing on the research and development, production, intelligent manufacturing and sales of products in four major fields, including liquid-based cells, tuberculous smear, thermostatic high-definition drop dyeing and ultra-strong adhesive glass slides.
Zhengzhou ZOPOMED advocates the spirit of professional craftsmanship. Since 2004, the company's core technology team has been committed to the research and development of products such as liquid-based cells, tuberculous smears, thermostatic high-definition drop dyeing, and ultra-strong adhesive glass slides. In this field, it has dozens of national patents and a number of international patent technologies. All products have all independent intellectual property rights, and can provide one-stop, automated Intelligent solutions provide diagnostic products with stable quality, professional technology and excellent performance for global medical laboratories.
Zhengzhou ZOPOMED pays attention to efficiency and pursues excellence. The company has 100000 purification workshops and 10000 purification laboratories. In the aspect of reagent production, it has introduced a full-automatic filling production line and automated, large-scale and standardized reagent production; In the aspect of intelligent manufacturing of medical equipment, we should strengthen fine management, control technology at all levels, and advocate process detection management; In terms of quality management system, the company has obtained the quality management system certification of national Class II diagnostic product ISO9001 and other quality system, and has strict quality management assessment to continuously promote product quality improvement.
Zhengzhou ZOPOMED is determined to become a global professional technology and product provider in four major fields: liquid-based cells, tuberculosis diagnosis, high-definition constant temperature drop dyeing and ultra-strong adhesive glass slides.
Zhengzhou ZOPOMED firmly believes that the future must belong to those enterprises that "focus" on a certain field and master core technology; It must belong to those enterprises that provide users with "professional" high-quality products and services.
Product research and development
Product production
Product intelligence
Product sales
Development path
Development path
2005
The liquid-based cell research and development team with Mr. Zhan Fengling as the core was established, and began to explore the path of independent research and development of Chinese liquid-based cell products.
2006
The team established Zhengzhou Keli Technology Co., Ltd. to start the research, development, production and sales of the first batch of liquid-based cell reagent consumables in China.
2008
The team created a research and development platform for liquid-based cell production equipment in the security zone of Shenzhen, and the first generation of automatic liquid-based cell production machine of the company was put into production that year.
2009
The liquid-based equipment R&D team returned to Zhengzhou to optimize, upgrade and innovate the liquid-based production equipment, and thoroughly solve the design defects of the liquid-based equipment in the industry!
2010
The team established Zhengzhou Zhongpu Medical Equipment Co., Ltd. and distributed the whole line of liquid-based cell products; The team independently completed the R&D and manufacturing of the third and fourth generation liquid-based equipment; The cert
2011
The team independently completed the research and development of the core technology of liquid-based cells-super adhesive, and launched the anti-detachment slide with quality comparable to that of the same kind in the United States; The team independently
2013
The team independently completed the research, development and manufacture of the seventh generation of rapid liquid-based cell production machine, and launched the landmark membrane sedimentation technology, which completely solved the defect of unstable
2014
The team independently completed the technical problems of sputum liquid-based cell preparation and mucus treatment, and launched a liquid-based cell preparation machine for lung cancer cells.
2015
Because the sputum cells were well made, the team stepped into the field of tuberculosis smear by chance to explore the technological innovation of liquid-based sandwich cup tuberculosis smear.
2016
The team independently completed the research and development of multiple models of automatic tuberculous smear machine, smear dyeing integrated equipment and supporting consumables; The team began to layout the research and development of automatic constant temperature high definition drop dyeing machine.
2017
The team independently completed the optimization and upgrading of the first generation automatic constant temperature high definition drop dyeing machine; The team layout explored the technology of artificial intelligence microscopic examination of tuberculosis smears.
2018
The tuberculosis team independently completed the optimization, upgrading and manufacturing of the high-precision hardware platform for automatic intelligent scanning; The intelligent team independently completed the research and development of multiple i
2019
The dyeing team independently completed the third generation of automatic thermostatic high-definition dyeing machine platform, and launched a series of automatic thermostatic high-definition dyeing machines and matching dyeing liquid consumables; The tub
2020
The intelligent team has independently completed the R&D and intelligent manufacturing of models A, B and C of intelligent scanners for tuberculosis smears, and launched the intelligent scanners for tuberculosis smears with Wiley‘s staining and fluorescen
2021
The team has independently completed the liquid-based cell intelligent upgrade product line, the tuberculosis smear intelligent diagnosis product line and the automatic thermostatic high-definition dyeing machine line; The team proposed to return to the f
